Uncategorized
Ocular Therapeutix™ Announces Christopher White as Senior Vice President, Head of Business and Corporate Development
BEDFORD, Mass.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX</a>--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the appointment of Christopher White as Senior Vice President, Head of Business and Corporate Development. “We are thrilled to welcome Chris to the Ocular team to oversee business and corporate development,” said Antony Mattessich, President and Chief E